Company news
EVE Health Group Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Quarterly Activities/Appendix 5B Cash Flow Report
October 23, 2024
Preliminary Final Report
August 30, 2024
Sale of Robyndale Property (Amended)
August 30, 2024
Sale of Robyndale Property
August 30, 2024
Sale of Jendale Property
April 29, 2024
Farm Sale and Funding Update
January 31, 2024
Appendix 4E - Results for Announcement to the Market
August 30, 2023
Appendix 4C - December Quarter 2022
January 31, 2023
Appendix 4C - September Quarter 2022
October 25, 2022
Appendix 4E and Preliminary Final Report
August 31, 2022
Appendix 4C - June Quarter 2022
July 27, 2022
Rights Issue Offer Document
June 5, 2022
Non-Renounceable Rights Offer
May 29, 2022
Notification regarding unquoted securities - EVE
May 2, 2022
Appendix 4C - March Quarter 2022
April 29, 2022
Update - Proposed issue of securities - EVE
April 20, 2022
Application for quotation of securities - EVE
February 27, 2022
$1.4m Share Placement
February 21, 2022
Appendix 4C - December Quarter 2021
January 31, 2022
Meluka Australia - Half Year Update
January 19, 2022
Change of Director's Interest Notice x 3
January 3, 2022
Alliance Agreement - Additional Information
December 6, 2021
Alliance Agreement - Australian Sales Force
December 5, 2021
Appendix 4C - September Quarter 2021
October 29, 2021
New Probiotic Product Range - Additional Information
October 19, 2021
Meluka Sales Performance Drives New Probiotic Product Range
October 18, 2021
Appendix 4C - June Quarter 2021 - Amended
August 5, 2021
Appendix 4C - June Quarter 2021
July 29, 2021
Appendix 4C - March Quarter 2021
April 29, 2021
Company Update
April 14, 2021
Appendix 4C - December Quarter 2020
January 27, 2021
Omni Innovation Enters Licencing Agreement
January 13, 2021
Appendix 4C - September Quarter 2020
October 18, 2020
Appendix 4C - June Quarter 2020
July 12, 2020
Appendix 4C - March Quarter 2020
April 15, 2020
Market Update - COVID-19 and operations
March 25, 2020
Quarterly Review
January 30, 2020
Tranche 1 Placement Funds Received
December 5, 2019
Reinstatement to Official Quotation
December 5, 2019
Voluntary Suspension
November 28, 2019
$9.3m Strategic Placement
October 6, 2019
Suspension from Official Quotation
September 29, 2019
Capital Raising Update
August 9, 2019
EVE Placement Raises $750k
July 12, 2019
Pause in Trading
July 11, 2019
Response to Appendix 4C Query
May 20, 2019
THC Global Agreement Update
May 14, 2019
Meluka Honey Secures Distribution for Northern NSW & SEQ
April 2, 2019
Placement
March 25, 2019
Meluka Honey Appoints OpenDNA for Chinese Market Entry
March 11, 2019
Decks
The 5 newest of 34 decks. Every deck is listed under its year.
- Investor Presentation (November 2026)
Investor deck · 18 slides · Nov 12, 2026
- Coffee Microcaps Conference (September 2026)
Conference · 18 slides · Sep 22, 2026
- Investor Presentation (March 2026)
Investor deck · 15 slides · Mar 26, 2026
- Investor Presentation (November 2025)
Investor deck · 14 slides · Nov 20, 2025
- Spark Plus Australian Equities Day 2025
Conference · 13 slides · Oct 3, 2025